
An Indian multicentre clinical trial investigated whether olanzapine can serve as a safe alternative to dexamethasone for preventing chemotherapy-induced nausea and vomiting in children.
The current standard regimen relies on dexamethasone, a corticosteroid that can trigger adverse health effects during cancer treatment.
Finding a comparable non-corticosteroid medication aims to help young patients better tolerate and complete highly emetogenic chemotherapy regimens.